Presentation is loading. Please wait.

Presentation is loading. Please wait.

David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD  The Lancet 

Similar presentations


Presentation on theme: "David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD  The Lancet "— Presentation transcript:

1 The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it? 
David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD  The Lancet  Volume 350, Pages S4-S9 (July 1997) DOI: /S (97) Copyright © 1997 Elsevier Ltd Terms and Conditions

2 Figure 1 Age-adjusted relative risk of CHD mortality in population-based and employment-based studies Comparison of men or women with diabetes mellitus (predominantly type 2) or impaired glucose tolerance (IGT). with non-diabetic, non-IGT population as reference group; studies 14, 23, 24, 57 may include some IGT or undiagnosed diabetic people in ‘non-diabetic’ control groups. The Lancet  , S4-S9DOI: ( /S (97) ) Copyright © 1997 Elsevier Ltd Terms and Conditions

3 Figure 2 Level of established risk factois of CHD in type 2 diabetic compared with non-diabetic populations Absolute value for risk factor in non-diabetic population subtracted from value in diabetic population and divided by non-diabetic value. Mean values expressed as percentage difference (SD bars) between diabetic and non-diabetic populations. From references 24, 25, 47, 58. The Lancet  , S4-S9DOI: ( /S (97) ) Copyright © 1997 Elsevier Ltd Terms and Conditions


Download ppt "David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD  The Lancet "

Similar presentations


Ads by Google